| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,135,000 | 1,124,000 | 1,008,000 | 1,421,000 | | Cost of Revenue | 911,000 | 895,000 | 824,000 | 1,094,000 | | | Gross Profit | 224,000 | 229,000 | 184,000 | 327,000 | | | Operating Expenses | | Research Development | 36,000 | 34,000 | 35,000 | 37,000 | | Selling General and Administrative | 159,000 | 156,000 | 159,000 | 195,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 29,000 | 39,000 | (10,000) | 95,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24,000) | 4,000 |
-
| (28,000) | | Earnings Before Interest And Taxes | 5,000 | 43,000 | (10,000) | 67,000 | | Interest Expense |
-
| 5,000 | 5,000 | 5,000 | | Income Before Tax | 5,000 | 38,000 | (15,000) | 62,000 | | Income Tax Expense | (12,000) | 14,000 | (1,000) | 7,000 | | Minority Interest | (2,000) | (2,000) |
-
|
-
| | | | Net Income From Continuing Ops | 15,000 | 22,000 | (14,000) | 55,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,000 | 22,000 | (14,000) | 56,000 | | Preferred Stock And Other Adjustments |
-
| 1,000 | (1,000) |
-
| | | Net Income Applicable To Common Shares | $15,000 | $23,000 | ($15,000) | $56,000 |
|
1.52% Nasdaq 0.00%
Income Statement
